Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone

References

• Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database of Syst Rev 2010;9:CD004332
   PubMed Web of Science ®Google Scholar
• Srisurapont M, Jarusuraisin N. Naltrexone for the treatment of alcoholism a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 2005;8:267–280
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Modesto-Lowe V, Van Kirk J. Naltrexone vs nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology 2000;22:493–503
   PubMed Web of Science ®Google Scholar
• Krystal JH, Cramer JA, William F, Kirk GF, Rosenheck RA. Naltrexone in the treatment of alcohol dependence. N Engl J Med 2001;345:1734–1739
   PubMed Web of Science ®Google Scholar
• Swift R, Oslin DW, Alexandrer M, Forman R. Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol 2001;72:1012–1018
   Google Scholar
• Bouza C, Angeles M, Munoz A, Amate J. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004;99:811–828
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Armeli S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn, R. Targeted naltrexone for early problem drinkers. J Clin Psychopharmacol 2003;23:294–304
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Tennen H, Armeli S, Chan G, Covault J, Arias A, Oncken, C. Targeted naltrexone for problem drinkers. J Clin Psychopharmacol 2009;29:350–357
   PubMed Web of Science ®Google Scholar
• Heinälä P, Alho H, Kiianmaa K, Lonnqvist J, Kuoppasalmi K, Sinclair JD. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blinded, placebo-controlled trial. J Clin Psychopharmacol 2001;21:287–292
   PubMed Web of Science ®Google Scholar
• Mann K, Bladström A, Torup L, Gual A, van den Brink W. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry 2012;73:706–713
   PubMed Web of Science ®Google Scholar
• World Health Organization: Global status report on alcohol 2004. ISBN 9241562722
   Google Scholar
• Anton RF, Moak DH, Latham PK, Waid LR, Myrick H, Voronin K, Thevos, A, et al. Naltrexone combined with either cognitive behavioural or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol 2005;25:349–357
   PubMed Web of Science ®Google Scholar
• Monterosso JR, Flannery BA, Pettinati HM, Oslin DW, Rukstalis M, O’Brien CP, Volpicelli JR. Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict 2001;10:258–268
   PubMed Web of Science ®Google Scholar
• Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press, 1985
   Google Scholar
• Capone C, Kahler CW, Swift RM, O’Malley SS. Does family history of alcoholism moderate naltrexone’s effects on alcohol use? J Stud Alcohol 2011;72:135–140
   Web of Science ®Google Scholar
• Chamorro A-J, Marco M, Mirón-Canelo J-A, Pastor I, Gonzáles-Sarmiento R, Francisco-Javier L. Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. Addiction Biol 2001;17:505–512
   Google Scholar
• Rothwell PM. External validity of randomized controlled trials: “To whom do the results of this trial apply?” Lancet 2005;365:82–93
   PubMed Web of Science ®Google Scholar
• Maxwell S, Shinderman MS. Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness. J Addict Dis 2000;19:61–69
   PubMed Web of Science ®Google Scholar
• Morris PL, Hopwood G, Whelan J, Gardiner E, Drummond E. Naltrexone for alcohol dependence. A randomized controlled trial. Addiction 2001;96:1565–1573
   PubMed Web of Science ®Google Scholar
• Moyer A, Finney JW. Randomized versus nonrandomized studies of alcohol treatment: participants, methodological features and posttreatment functioning. J Stud Alcohol 2002;63:542–550
   PubMedGoogle Scholar
• Sinclair D, Jacobson, B. ConrAl Clinics treatment manual. Unpublished manual, 1996
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed.) Washington, DC: American Psychiatric Press, 1994
   Google Scholar
• Anton, RF, Moak DH, Latham PK. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 1995;19:92–99
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Keskiner A, Schinaka J, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232–241
   Web of Science ®Google Scholar
• Anton RF, Moak DH, Latham PK. The Obsessive Compulsive Drinking Scale. A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996;53:225–231
   PubMed Web of Science ®Google Scholar
• Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy for depression: a treatment manual. New York: The Guilford Press, 1997
   Google Scholar
• Feinn R, Tennen, H, Cramer J, Kranzler HR. Measurement and prediction of medication compliance in problem drinkers. Alcohol Clin Exp Res 2003;27:1286–1292
   PubMed Web of Science ®Google Scholar
• Jones LJ, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them, 2007
   Google Scholar
• Jones BL, Nagin DS, Roeder KA. SAS procedure based on mixture models for estimating developmental trajectories, 2001. http://www.contrib.andrew.cmu.edu/~bjones/pdf/ref1.pdf
   Google Scholar
• Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol 2001;36:2–10
   PubMed Web of Science ®Google Scholar
• Vuoristo-Myllys S, Lahti J, Alho H, Julkunen J. Predictors of dropout from an outpatient treatment for problem drinkers including cognitive behavioral therapy and opioid antagonist naltrexone. Accepted for publication in J Stud Alcohol, 2013;74:894--901
   Google Scholar
• Vuoristo-Myllys S, Laaksonen E, Lahti J, Lipsanen J, Alho H, Kalska H. Predictors of self-reported adherence to naltrexone medication in an outpatient treatment for alcohol dependence. Accepted for publication in J Addict Res Ther
   Google Scholar
• Baros AM, Latham PK, Moak DH, Voronin K, Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res 2007;31:596–603
   PubMed Web of Science ®Google Scholar
• Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 2000;35:587–593
   PubMed Web of Science ®Google Scholar
• O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 1992;49:881–887
   PubMed Web of Science ®Google Scholar
• Volpicelli JR, Clay KL, Rhines JS, Volpicelli LA, Alterman AI, O’Brien CP. Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiat 1997;54:737–742
   PubMed Web of Science ®Google Scholar
• Namkoong K, Farren CK, O’Connor PG, O’Malley S. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. J Clin Psychiatry 1999;60:449–453
   PubMed Web of Science ®Google Scholar
• Hughes DA, Bagust A, Haycox A, Walley, T. The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econon 2001;10:601–615
   PubMed Web of Science ®Google Scholar
• Pettinati HM. Improving medication adherence in alcohol dependence. J Clin Psychiatry 2006;67:23–29
   Web of Science ®Google Scholar
• Pettinati HM, O’Brien CP, Rabinowitz BA, Wortman SM, Oslin MD, Kampman KM, Dackis CA. The status of naltrexone in the treatment of alcohol dependence. Specific effects on heavy drinking. J Clin Psychopharmacol 2006;26:610–625
   PubMed Web of Science ®Google Scholar
• Chen J, Johnson BA, Wang XQ, O’Quigley J, Isaac M, Zhang D, Liu, L. Trajectory analyses in alcohol treatment research. Alcohol Clin Exp Res 2012;36:1442–1448
   PubMed Web of Science ®Google Scholar